Positioning newer drugs in the management of type 2 diabetes

被引：1
|
作者：
Marx, Nikolaus [1 ]
Davies, Melanie J. [2 ]
Grant, Peter J. [3 ]
Mathieu, Chantal [4 ]
Petrie, John R. [5 ]
Cosentino, Francesco [6 ,7 ]
Buse, John B. [8 ]
机构：
[1] Rhein Westfal TH Aachen, Dept Internal Med, Univ Hosp Aachen, Aachen, Germany
[2] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England
[3] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England
[4] Katholieke Univ Leuven, Univ Ziekenhuis Gasthuisberg, Clin & Expt Endocrinol, Leuven, Belgium
[5] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[6] Karolinska Inst, Dept Med, S-17176 Stockholm, Sweden
[7] Karolinska Univ Hosp, S-17176 Stockholm, Sweden
[8] Univ N Carolina, Dept Med, Sch Med, Chapel Hill, NC 27515 USA
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2021年 / 9卷 / 03期
关键词：
D O I：
10.1016/S2213-8587(21)00021-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：139 / +
页数：3
相关论文
共 50 条
  • [1] Guideline recommendations and the positioning of newer drugs in type 2 diabetes care
    Marx, Nikolaus
    Davies, Melanie J.
    Grant, Peter J.
    Mathieu, Chantal
    Petrie, John R.
    Cosentino, Francesco
    Buse, John B.
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (01): : 46 - 52
  • [2] Guideline recommendations and the positioning of newer drugs in type 2 diabetes care (vol 9, pg 46, 2021)
    Marx, N.
    Davies, M. J.
    Grant, P. J.
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (01): : E1 - E1
  • [3] What are the cardiovascular effects of the newer classes of drugs or type 2 diabetes?
    Covino, Jean
    Hoffman, Jennifer
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2018, 31 (03): : 12 - 14
  • [4] Oral hypoglycaemic drugs and newer agents use in TYPE 2 DIABETES MELLITUS
    Joshi, P.
    Joshi, S.
    SA PHARMACEUTICAL JOURNAL, 2008, 75 (09) : 38 - 43
  • [5] Oral hypoglycaemic drugs and newer agents use in Type 2 diabetes mellitus
    Joshi, P.
    Joshi, S.
    SOUTH AFRICAN FAMILY PRACTICE, 2009, 51 (01) : 10 - +
  • [6] Efficacy of newer agents in the glycaemic management of patients with type 2 diabetes
    Chudleigh, Richard A.
    Bain, Steve C.
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (02) : 209 - 211
  • [7] Newer insulins in type 2 diabetes
    Gale, Edwin A. M.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [8] Newer Pharmacologic Treatments for Type 2 Diabetes
    Laine, Christine
    Moyer, Darilyn V.
    Qaseem, Amir
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (07) : 968 - 969
  • [9] Positioning of the glitazones in type II diabetes management
    不详
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2003, 93 (04): : 284 - 285
  • [10] Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?
    Burguera, Bartolome
    Ali, Khawla F.
    Brito, Juan P.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2017, 84 : S39 - S46
12345